As we begin the New Year and continue taking on pancreatic cancer, here is a recap of some of our top stories on social media for 2017.
We held another successful Annual summit last year, which focused on ‘Inspiring Innovation’. The day brought together researchers, health professionals and people affected by the disease to hear about the progress being made in diagnosis, treatment and research
Our Every Month Matters petition called for fairer access to life-extending treatments for people with pancreatic cancer. We called on the bodies responsible for approving life-extending treatments on the NHS to take into account the huge value of extra time for people with just a few months left to live.
A research project sponsored by our Research innovation Fund saw scientists take exciting steps towards the development of a blood test which could be used for detecting and improving the treatment of pancreatic cancer.
Our team of 118 runners supported us by taking on the world's most renowned marathon and ran a 26.2 mile race past the capital’s most famous landmarks. We raised a fantastic £361,000. Thank you #TeamPanCanUK!
We surveyed leading cancer researchers as part of our Research At Risk campaign. 92% felt Brexit could negatively impact access to EU research funding. Research is the only way to find new treatment options, so we asked our supporters to help us encourage the government to guarantee access to EU clinical trials, post-Brexit.
Many of our supporters tuned in to listen to actress Alison Steadman present our BBC Radio 4 Appeal which raised an incredible £34,730. Alison talked about her mum’s battle with pancreatic cancer 21 years ago and asked for your help to fund cutting-edge research, led by some of the brightest minds in the field.
People with the six less survivable cancers are almost five times less likely to survive beyond five years. That’s why we joined forces with four cancer charities to form the Less Survivable Cancers Taskforce and demand all cancer patients have a fair chance of living for longer.
A pilot treatment pathway funded by Pancreatic Cancer UK demonstrated the potential to save the NHS an astonishing £3,200 per patient. Through our Clinical Pioneers Awards, we continue to fund pioneering research to improve diagnosis, treatment and care.
The launch of our Future leaders Academy saw us fund five of UK’s brightest PHD students at the Beatson Institute in Glasgow as they began their research careers. Their research could help develop new treatments and make the breakthroughs that are so desperately needed.
We achieved some fantastic awareness raising throughout November last year. Our various news stories generated 965 pieces of media coverage reaching at least 55 million people. We also reached over 2 million people through our Facebook posts, which received over 86,000 engagement likes, comments and shares in total.
50 of the brightest minds from the UK's best research centres were brought together last November to discuss a new strategy for taking on the early diagnosis of pancreatic cancer. We will now fund our Dream Team to deliver the early diagnosis research study over the next three years.
Our 2016-17 Impact Report highlighted the incredible work we’ve done with our supporters to take on pancreatic cancer. Thanks to their help we reached more people than ever before with our support services, helped increase standards of care, invested 2.4 million in research, campaigned for policy change and took a leading role in building a stronger pancreatic cancer community.